✦ LIBER ✦

Interleukin-2 and type 1 diabetes: New therapeutic perspectives

✍ Scribed by A. Hartemann; O. Bourron

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interleukin-1 receptor antagonist: A new

✍ Muhammad Sajid Hamid Akash; Qi Shen; Kanwal Rehman; Shuqing Chen 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB

Type 1 diabetes: new perspectives on dis

✍ Mark A Atkinson; George S Eisenbarth 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 114 KB

Type 2 diabetes mellitus: epidemiology,

✍ M. Virally; J.-F. Blicklé; J. Girard; S. Halimi; D. Simon; P.-J. Guillausseau 📂 Article 📅 2007 🏛 Masson Editeur 🌐 French ⚖ 559 KB

[RSC Drug Discovery] New Therapeutic Str

✍ Jones, Rob M 📂 Article 📅 2012 🏛 Royal Society of Chemistry ⚖ 388 KB

Reducing the risk of stroke in type 2 di

✍ Dirk Sander; Mark T. Kearney 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 394 KB

Glucokinase activators as new type 2 dia

✍ Sarabu, Ramakanth; Berthel, Steven J; Kester, Robert F; Tilley, Jefferson W 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 411 KB